Supernus, Inc. (SUPN)
Last updated: 2026-11-11 01:40:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Supernus, Inc. (SUPN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $28.76, with a market capitalization of $1.52B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $25.92 to $59.68. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.52B | |
$27.61 | |
$61.25 | |
$4.30 | |
$27.62 | |
2.10M | |
1.24M | |
-- | |
$59.68 | |
$25.92 | |
-- | |
-- |
Supernus, Inc. (SUPN) Latest Closing Stock Price
Supernus, Inc. (SUPN) last closed at $27.62 as of 2026-11-11 00:31:00, unchanged from the previous close of $27.62.
During the latest regular trading session, SUPN traded between $4.30 and $61.25, with a volume of 2.10M shares. The closing price was near the middle and near the lower end of its 52-week range.
Supernus, Inc. (SUPN) 7-Day Stock Price Change
Over the past seven days, Supernus, Inc. (SUPN) moved from $41.84 to $28.76, representing a decline of 31.26% ($13.08).
The stock traded between $25.92 and $44.31 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 5.22 million shares, up versus the previous seven-day period, indicating higher trading activity.
SUPN 52-Week Price Position
Position in Range: 8.4%
SUPN is currently trading at $28.76, placing it 8.4% of the way from its 52-week low of $25.92 to its 52-week high of $59.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Supernus, Inc. (SUPN)?
Supernus Inc is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The company's commercial portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.
Supernus, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 778 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Supernus, Inc. (SUPN) Stock on MEXC
Eligible investors can buy real shares of Supernus, Inc. (SUPN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Supernus, Inc. (SUPN) stock price today?
2.Is SUPN stock going up or down today?
3.What is SUPN pre-market price?
4.What is SUPN after-hours price?
5.Is SUPN stock trading now?
6.Where does SUPN sit relative to its 52-week high and low?
7.What sector is Supernus, Inc. in?
8.What is Supernus, Inc.'s market capitalization and where is it listed?
9.How is SUPN valued in terms of P/E ratio and EPS?
10.Does Supernus, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
SUPN Stock Calculator
Estimate the value between SUPN shares and USD.
SUPN Shares to USD
1.00 SUPN shares = 28.759 USD
Calculations are estimates based on the latest available price and are for reference only.



